Communiqués Avicanna Inc.

Actions

AVCN

CA05368K1003

Temps Différé Toronto S.E. Autres places de cotation 15:35:38 08/07/2024			Varia. 5j.	Varia. 1 janv.
0,43 ^CAD	-2,27 %		+22,86 %	+22,86 %

19/06	Avicanna annonce la délivrance par l'Office américain des brevets et des marques d'un brevet sur la technologie SEDDS	CI
14/05	Avicanna en hausse de 4,5 % avec un revenu record pour le premier trimestre et le premier trimestre à BAIIA ajusté positif de l'histoire de la société	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Avicanna General Meeting	19/06	AQ
Avicanna Announces USPTO Issuance of Patent SEDDS Technology	19/06	AQ
Avicanna to Present at the Life Science Investor Forum June 20th, 2024	18/06	AQ
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter	14/05	AQ
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa	13/05	AQ
Avicanna Announces Closing of Non-brokered Private Placement	18/04	AQ
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study	10/04	AQ
Avicanna Reports Full Year 2023 Audited Financial Results	02/04	AQ
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27/03	AQ
Avicanna To Hold Full Year 2023 Earnings Conference Call	26/03	AQ
Avicanna Hosts Symposium on Cannabinoid-based Medicine	29/02	AQ
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company	15/02	AQ
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox	14/02	AQ
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™	13/02	AQ
Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company	05/02	AQ
Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil	30/01	AQ
Avicanna Reports Q3 2023 Results	14/11	AQ
Avicanna Announces Appointment of Paul Fornazzari to Board of Directors	13/11	AQ
Avicanna To Hold Third Quarter 2023 Earnings Conference Call	01/11	AQ
Avicanna Provides Update on the Successful Launch of MyMedi.ca	11/10/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Avicanna Inc.

Actions

AVCN

CA05368K1003

Communiqués

Filtres